Reduced Milk Production in Udder Quarters with Subclinical Mastitis and Associated Economic Losses in Crossbred Dairy Cows in Ethiopia

The objective of the study was to estimate the losses associated with subclinical mastitis (SCM) in crossbred dairy cows in the Central Highlands of Ethiopia. A split udder investigation was performed with 30 cows to determine production losses associated with SCM. Each quarter of the study cows was examined using the California Mastitis Test (CMT) and quarter milk production was measured over a period of 8 days. Production losses were determined for different CMT scores by comparing production of quarters with CMT score 0 to quarters with CMT scores trace, 1, 2 and 3, respectively. Using data from a recently published study, economic losses were determined for different farm sizes and production subsystems by multiplying the prevalence of the respective CMT scores with the production losses associated with these CMT scores. Mean quarter milk production was 0.82 + 0.40 kg per milking in the split udder trial. Milk production was reduced by 1.2%, 6.3%, and 33% in quarters with CMT scores 1+, 2+, and 3+, respectively. Using data from the published study, a quarter with SCM lost an average of 17.2% of its milk production. Production losses associated with SCM were estimated at 5.6% for the Addis Ababa Milk Shed. Stratified losses were highest (9.3%) in urban dairy farms (UDF) and small-scale farms (6.3%). The estimates of the financial losses ranged from US$29.1 in dairy herds in secondary towns (DHIST) to US$66.6 in UDF. A total loss of US$38 was estimated for each cow per lactation. Reducing mastitis in UDF (highest prevalence) to the level of DHIST (lowest prevalence) could reduce the loss by US$35. As this does not include costs associated with treatment or culling of diseased cows, this figure probably underestimates the possible benefits of control measures.     

Milk losses associated with somatic cell counts per breed, parity and stage of lactation in Canadian dairy cattle

The reduction in milk production caused by subclinical mastitis in dairy cattle was assessed through the regression of test day milk yield on log-transformed somatic cell counts (LnSCC). Data was obtained from Valacta, Quebec, and a total of 312,756 test day records from Ayrshire cows and 1,869,785 test day records from Holstein cows were included in the analyses. A segmented regression was fitted to estimate the cutoff point in the LnSCC scale where milk yield starts to be affected by mastitis. The statistical model used to explain daily milk yield included the effects of herd–year-season of test (random), days in milk, age at calving and LnSCC, and analyses were performed by breed, parity and stage of lactation. The cutoff point where milk yield starts to be affected by changes in LnSCC was estimated from data to be around 2 (approximately 7400 cells/mL) for Canadian Ayrshires and Holsteins. Milk losses per unit increase in LnSCC varied from 0.55 to 0.84 kg/day in first lactation Ayrshires, from 0.33 to 0.55 kg/day in first lactation Holsteins, from 0.74 to 2.45 kg/day in adult Ayrshires and from 0.77 to 1.78 kg/day in adult Holsteins. Daily milk losses caused by changes in LnSCC were dependent on breed, parity and stage of lactation, and these factors should be considered when estimating losses associated with subclinical mastitis.     

Association between exposure to Neospora caninum and milk production in dairy cows

OBJECTIVE: To determine association between exposure to Neospora caninum and milk production in dairy cows. DESIGN: Prospective observational study. Animals: 565 Holstein cows. PROCEDURE: Cows were classified as seropositive or seronegative to N. caninum within 7 days after calving by use of a kinetic ELISA. Milk production was compared between seropositive and seronegative cows. RESULTS: On the basis of 305-day mature equivalent milk production data, seropositive cows produced less milk (2.8 lb/cow per day) than did seronegative cows. In addition, analysis of results throughout the first 300 days of lactation revealed that after adjusting for effects of lactation number, calving season, clinical mastitis, and lameness, milk weight of seropositive cows was 2.5 lb/cow per day less than that of seronegative cows. CONCLUSIONS AND CLINICAL RELEVANCE: Exposure to N. caninum was associated with a 3 to 4% decrease in milk production. A decrease in milk production of 800 lb/cow for a typical 305-day lactation represents a loss of $128/cow.     

Bovine respiratory syncytial virus reinfections and decreased milk yield in dairy cattle

Summary

The influence of Bovine Respiratory Syncytial Virus (BRSV) reinfections on the daily milk yield was studied by evaluating the milk production of 32 BRSV reinfected cows. For the estimation of milk production losses, four lactation curve models were used, including a gamma function, a second degree polynomial, and both of these models with a lag variable. Bovine respiratory syncytial virus reinfections seemed to have only a small effect on the daily milk production. Comparison of the true production with an estimated production according to the gamma function showed that the production for first lactation cows dropped 0.14 kg on average and for cows in their second or later lactation 0.56 kg on average, during 5 consecutive days in the infection period. For the second‐degree polynomial model these values were respectively 0.42 kg and 0.80 kg. All calculated average production losses were relatively small and not significant (P>0.15). The models without lag variable were more suitable than the models with the lag variable to estimate small production losses caused by BRSV reinfections. The power of this study was sufficient to detect a decrease in production of approximately 1 ‐ 1.5 kg milk per cow per day. It was therefore concluded that BRSV reinfections were not associated with an important loss of milkproduction.     

Disease, production and culling in Holstein-Friesian cows: IV. Effects of disease on production

The effects of common clinical and two subclinical disease conditions (mastitis and ketosis) on milk production and reproductive performance in Holstein-Friesian cows were investigated in a two and a half year study. The data used were from 1315 lactation records and results from tests performed on 6241 composite milk samples.

Path analyses were used to estimate the direct and indirect impact of disease on days to conception, milk production in a standard 305 day lactation and milk production per day. Indirect effects accounted for a large percentage of the total effect of some diseases on production. The path coefficients were quite sensitive to the units used to measure production, with deviation from the herd average being the preferable measure. These units controlled confounding due to herd level variables. Effects identified by the path analyses were substantially different from those determined on the basis of unconditional associations between diseases and production parameters.

Subclinical mastitis and the reproductive diseases (most of which were subclinical in nature) were found to have the greatest detrimental impact on milk production per day. Several disease conditions had a beneficial effect on milk production and this was attributed to the therapy provided to cows affected with these conditions. All conditions related to reproductive performance had a detrimental effect on days to conception.     

Milk yield and associated economic losses in quarters with subclinical mastitis due to <Emphasis Type="Italic">Staphylococcus aureus</Emphasis> in Ethiopian crossbred dairy cows

The objective of the study was to estimate the prevalence and losses associated with subclinical mastitis (SCM) caused by Staphylococcus aureus in Ethiopian crossbred dairy cows. A split-udder trial was carried out to determine milk yield losses in udder quarter with S. aureus-caused SCM. Each quarter of the study cows was examined using the California Mastitis Test (CMT) and quarter milk production was measured over a period of 8 days. Milk yield losses for CMT positive quarters were estimated by comparing production of quarters with CMT score 0. Mean milk yield for uninfected healthy quarters was 1.66 kg per milking (95% CI, 1.66–1.55 kg per milking), and the rate of milk reduction for quarters with CMT scores of 1+, 2+, and 3+ was 25%, 33%, and 48%, respectively. Economic losses at different farm-size levels were calculated by multiplying the prevalence of CMT scores with milk yield losses associated with respective CMT scores. In Debre Ziet dairy herds, a quarter with SCM due to S. aureus lost an average of 34.5% of its potential milk production while the total milk yield loss per cow was estimated at 6.8%. Losses were highest in large-scale (13%) farms and lowest (3.7%) in small-scale. Based on the prevalence, the overall financial loss for each cow per lactation was 984.64 Eth Birr (US78.65) and losses in large farms (1,882.40 Eth Birr or US78.65) and losses in large farms (1,882.40 Eth Birr or US150.35) were over 3.5 times the loss in small-size farms. These figures possibly underestimate the potential benefits of mastitis control program as they do not include other direct and indirect costs.     

Effects of peripartum biotin supplementation of dairy cows on milk production and milk composition with emphasis on fatty acids profile

Forty Holstein dairy cows receiving a 38% concentrate diet based on maize silage were assigned to either a control group, either a biotin group, receiving 20 mg of biotin per day from 15 days before expected calving date and for 120 days after calving. Milk production was measured daily, milk fat content, protein content, urea and somatic cell counts were determined weekly from week 2 to week 17 of lactation. The profile of milk fatty acids was determined at weeks 3 and 10. Plasma glucose and blood beta-hydroxybutyrate were determined before calving and at weeks 1, 2, 3, 5, 7 and 10 of lactation.

Biotin supplementation resulted in an increased milk production in multiparous cows during weeks 2 to 6, but the effect was no more significant between 7 and 17 weeks of lactation. Milk protein percent was decreased by 0.1% in multiparous cows. Milk fat content was not affected by biotin, and milk fat daily production tended to increase during early lactation. In milk fat, biotin supplementation tended to decrease the proportion of fatty acids with less than 16 carbons at week 3, but the daily amount was not affected. Biotin tended to decrease biohydrogenation intermediates, increased C16:1 at week 3, and tended to increase cis-9 C18:1 at weeks 3 and 10. After 7 weeks of lactation, biotin tended to increase blood beta-hydroxybutyrate in multiparous cows with values remaining in a normal range, and decreased plasma glucose in primiparous cows. These modifications of plasma parameters, milk protein content and profile of milk fatty acids could be due to a higher lipid mobilisation from adipose tissue driven by the increased milk production.     

Effect of mastitis during the first lactation on production and reproduction performance of Holstein cows

The aim of this study was to evaluate the effect of postpartum mastitis between first calving and subsequent conception on production and reproduction performance as well as culling of Holstein cows. A data set of 9,183 first lactation cows was used. Results showed that the first cumulative 100?days' milk production and the milk yield standardized to 305?days were affected by the interval from calving to first mastitis (P??0.05). Calving year, calving difficulty score, and cumulative first 60?days milk production had significant impacts on mastitis risk (P?相似文献   

An investigation of mastitis due to S agalactiae, S uberis and M smegmatis in a dairy herd

Subclinical mastitis caused by streptococcal infections affected 27 of 83 cows in a commercial dairy herd. Between three and six weeks after intramammary treatment of these cows with cloxacillin, 16 (59 per cent) of the treated cows developed acute clinical mastitis associated with Mycobacterium smegmatis. None of the untreated cows was affected. Infected quarters were moderately hypertrophied and fine clots were present in the milk for three to four weeks. No cows showed systemic signs of illness. Studies carried out over 12 months showed that infected cows shed M smegmatis for three to four months and affected quarters remained hypertrophied in all but one cow after 12 months. The mean milk cell count of affected quarters fell slowly from 4,850,000/ml in the acute stage to 810,000/ml five months later and 620,000/ml 12 months later, suggesting that the organism persisted in the udder. The estimated mean loss in lactation yield for cows with M smegmatis mastitis was 10.8 per cent. Losses were greatest when the hind quarters were involved (mean 28 per cent for cows with both hind quarters affected). Ten of the 16 affected cows were ultimately culled owing to serious reductions in yield.     

Economic and reproductive consequences of retained placenta in dairy cattle

The financial losses due to retained placenta in Dutch dairy cattle were estimated by using two different methods of calculation. A data-set containing the birth records of 160,188 Meuse-Rhine-Yssel cows provided data on the reproductive performance of cows with and without retained placenta. The fertility of cows after retention of the placenta appeared to be affected. An economic calculation made by adding the losses due to increased calving interval, increased culling rate, loss of milk production and the costs of veterinary treatment and drugs revealed that the total loss due to retained placenta was 471 pounds per year for a 100-cow farm with an average incidence of the condition (6.6 per cent). For a 'problem' farm with a 30 per cent rate, the loss was 2139 pounds per year. A computer farm simulation model, based on a stochastic determination of events, was used to make calculations for circumstances closely resembling those on farms. A 6.6 per cent rate of retained placenta caused a small but significant decrease in net return on labour and management; however, a 30 per cent rate caused highly significant changes. The economic effects of retained placenta were similar in magnitude in herds of high or low productivity and high or low fertility. Sensitivity analysis showed that the greatest financial losses were caused by loss of milk production, followed by the number of animals suffering from complications. The financial losses in herds with an average rate of retained placenta were thus of limited economic importance and therapeutic measures alone should be adequate.(ABSTRACT TRUNCATED AT 250 WORDS)     

Relation of milk production loss to milk somatic cell count.

Milk production loss was studied in relation to increased somatic cell count (SCC). Available data were weekly test-day milk yields and SCC (in 1,000 cells/ml), and mastitis incidences. In total, 18,131 records from 274 cows were used. Production loss was determined for test-day kg milk, kg protein, and kg energy-corrected milk. Least-squares analysis of variance was used to estimate the direct effect of Log10(SCC) on production. The recorded measures of production were first corrected for fixed effects, with adjustment factors estimated from a healthy data-set. The average daily milk yield was 19.7 kg/day in first lactation and 22.0 in later lactations. The geometric mean of SCC was 63.1 in first lactation and 107.2 in later lactations. The incidence of clinical mastitis treated by a veterinarian was 19.8% of the lactations-at-risk. Linear relationships were found between the production parameters and Log10(SCC). Quadratic and cubic effects were evaluated, but were found to contribute little to the overall fit of the models. The individual milk yield loss was 1.29 kg/day for each unit increase in Log10(SCC) for cows in first lactation. Milk yield decreased by 2.04 kg/day per unit Log10(SCC) for older cows. Corresponding values for protein yield were 0.042 and 0.067 kg/day for first and later lactations, respectively.     

The economic benefit of treating subclinical Streptococcus agalactiae mastitis in lactating cows

The economic benefits of treating lactating cows for Streptococcus agalactiae mastitis were studied at a large (689 milking cows) central California dairy. Postcure milk production of case cows (infected, treated, and cured) was compared with production of paired control cows (uninfected) and was matched for yield, days in milk, days in gestation, and parity. A simulation was used to plot expected lactation curves for mastitic cows (infected, not treated) with characteristics similar to those of each control cow, and these curves were compared with actual case-cow lactation curves. The difference in actual and expected production was used to calculate net economic benefits of treatment. Comparison of expected with actual production indicated a net benefit from treatment of $396/cow for cows treated in early lactation and $237 for cows treated in midlactation, but a net loss of $55 for cows treated in late lactation. Lactation number did not have a significant impact on economic benefits of treatment. In contrast to other studies indicating no economic benefit from treating mastitis during lactation, this study's positive results may have been attributable to the high cure rate (98%) and the subclinical form of mastitis being treated. Streptococcus agalactiae mastitis treatment during early and midlactation would appear to be an economically justifiable option for dairy managers.     

Stillbirth parturition reduces milk production in Holstein cows

Stillbirth is defined as calf mortality shortly before, during, or shortly after parturition. Economic losses to the dairy industry in the U.S. just due to the loss of replacement heifers were estimated to be $125 million per year. Our objective in this study was to evaluate the effect of stillbirth on the dam's subsequent lactation. Data were collected from 20 farms in the U.S.A. (19 from NY, one from IN) from May 2005 until September 2006. Calving-ease scores (scale of 1-5; no problem and extreme difficulty, respectively) and stillbirths were recorded by farm personnel. We used 32,299 calvings for the final analysis where 6.5% of the calvings were stillbirths. The incidence of stillbirths for primiparous cows was 10.7% (of 11,891) and 4% (of 20,408) for multiparous cows. Stillbirth parturition significantly reduced milk production (-1.1 kg/day). The losses in milk production were evaluated in a generalized mixed linear model analysis. The daily milk production for cows with stillbirths was 34.2 kg, compared to 35.3 kg for the cows that had a live calf. Milk-production reduction was greatest early in lactation and declined afterwards. Economic losses from stillbirths include not just the lost calf, the reduced survival, and increased days open but also the decreased milk yield.     

Loss in milk yield and related composition changes resulting from clinical mastitis in dairy cows

Relationships between clinical mastitis and milk yield and composition in dairy cows were reviewed. Requirements for inclusion were: data had to be collected after 1975; dependent variables for milk yield and milk composition had to be defined at the cow level; mastitis cases had to be defined by clinical signs, and at least 250 lactations had to be considered. Twenty studies dealing with milk-yield loss and, for four of them, also with related composition changes were selected. Study populations, design of data collection, and analysis methods differed widely between studies. As expected from these differences – but also due to structural-variation factors such as type of pathogen, animal and production level – estimates for milk-yield losses differed in average magnitude and pattern. Literature data regarding changes in milk-fat % and total-protein % changes were contradictory. Critiques of materials and methods allowed us to propose some final recommendations for values to be used as basic inputs in economic calculations of losses caused by mastitis.     

规模化奶牛场奶牛亚临床型乳房炎流行规律调查

目的 本研究旨在摸清兰考县规模化奶牛场奶牛亚临床乳房炎流行规律,为该病的防控提供参考。方法 采用加州奶牛亚临床乳房炎试验（CMT）方法对3 家规模化奶牛场的547 头泌乳奶牛进行亚临床乳房炎检测,调查该病与奶牛胎次、泌乳期和乳区的关系。结果 奶牛阳性率为20.11%,乳区阳性率为10.88%;1~2、3~4和≥5胎次的奶牛发病率分别为13.37%、20.53%和29.46%;泌乳前期、泌乳中期和泌乳后期发病率分别为15.11%、22.12%和30.89%;乳区阳性率介于8.59%~13.16%。结论 兰考县规模化奶牛场奶牛亚临床型乳房炎的发病率相对较低,与胎次、泌乳期存在正相关,与乳区无明显关系。     

胎次和泌乳阶段对奶牛体细胞数和乳损失量的影响

通过奶牛生产性能（dairy herd improvement,DHI）测定体细胞数,探究奶牛的胎次及其不同泌乳阶段对其乳体细胞数（somatic cell count,SCC）和乳损失量的影响。通过对某养殖场泌乳期奶牛DHI的测定进行分析,结果表明：体细胞评分（somatic cell score,SCS）随奶牛胎次的增加而增加,但SCS在不同胎次的不同泌乳阶段表现有所不同。一胎牛SCS随着泌乳期的延长而增加,前期、中期与后期的SCS呈显著性差异（P＜0.05）;二胎牛与三胎牛SCS呈现相同变化规律,泌乳前期的SCS较泌乳中期高,而泌乳后期SCS显著高于前2个泌乳阶段（P＜0.05）。乳损失量随胎次的增加整体呈现增加趋势,且泌乳早期和泌乳后期乳损失量高于泌乳中期。     

Effects of clinical mastitis on reproductive and milk performance of Holstein cows in Morocco

The aim of this study was to determine the influence of clinical mastitis and time of first mastitis occurrence on reproductive and milk performance of Holstein cows. Data were collected in a dairy farm from 2008 to 2012 on 1725 cows, among which 464 cows with mastitis. To determine the influence of clinical mastitis on reproductive and milk performance, models included fixed effects of parity, calving season, calving year, and group (cows with and with no mastitis). To determine the effect of time of 1st mastitis occurrence on reproductive performance, the mastitic cows group was further reclassified into three groups: prior to 60 days, between 60 and 90 days and greater than 90 days postpartum. For milk performance, the mastitic cows group was divided into two groups: before and after peak milk yield. Clinical mastitis had significant effects on calving to first AI interval, milk yield, and fat yield, but a non-significant effect on days open, number of inseminations per conception, and milk fat percentage. Mastitic cows had a calving to first AI interval 6.1 days longer and 549.6 kg milk and 20.4 kg fat per 305 days of lactation lower than those with no mastitis. Time of 1st mastitis occurrence did not have any significant effect on reproductive performance. Further, milk and fat yields of cows diseased before peak milk yield were 506 kg and 23.9 kg, respectively, lower than those of cows affected after peak milk yield. Extra attention needs to be paid to mastitis during the early postpartum period.

     

Relationships between age at first calving and first lactation milk yield, and lifetime productivity and longevity in dairy cows

Lifetime records of 442 Holstein cows on one farm in North Queensland, Australia, were analysed to evaluate the effects of age at first calving (AFC) and first lactation milk yield on parities per lifetime, longevity, milk yield in subsequent lactations, lifetime milk production and the longevity index (LI), that is the proportion of a cow's life spent in active milk production. The mean daily yield in the first lactation was a reliable indicator of milk yield in subsequent lactations, estimated lifetime production, longevity and LI. The afc had no effect on lifetime days in milk. Neither the AFC nor the milk yield in the first lactation significantly affected the number of parities per lifetime. For the majority of cows, which produced less than 30 l/day in the first lactation, there was a significant positive relationship between longevity and AFC. However, none of the cows that produced more than 30 l/day in the first lactation survived for more than two lactations. The optimal AFC was thus two to two-and-a-half years, as these cows had the highest first lactation yield, estimated lifetime production and LI. The optimal mean daily yield in the first lactation was 20 to 30 l/day, as these cows lived longer and had a higher LI and lifetime production.     

Pilot study--parenteral treatment of recently acquired subclinical mastitis during lactation

OBJECTIVE: To conduct a pilot study to investigate the effect of parenteral antibiotic treatment with penethamate hydriodide on recently acquired sub-clinical mastitis. DESIGN: Sixty-nine cows from five Western Victorian dairy farms were enrolled in a pilot trial. Cows that had an Individual Cow Cell Count (ICCC) of greater than 250,000 cells per mL in their milk at their first or second herd test were enrolled in the trial if they were in their first lactation, or if they had a history of ICCCs below 250,000 cells per mL at all herd tests during the previous lactation. These criteria were used in an effort to exclude cows with chronic subclinical mastitis and include cows with recently acquired subclinical mastitis. PROCEDURE: Cows were divided into control and treatment groups on the basis of having an odd or even ear tag number. The treatment group was treated with penethamate hydriodide shortly after the first or second herd test; the control group was left untreated. The ICCCs of subsequent herd tests were recorded for the remainder of lactation. RESULTS: In 58% of the treatment group, and 25% of the control group, all subsequent ICCCs for that lactation were less than 250,000 cells per mL (p < 0.05). If only first and second lactation cows were considered, 72% of the treatment group, and 11% of the control group, had subsequent ICCCs less than 250,000 cells per mL (p < 0.05). CONCLUSION: An ICCC of greater than 250,000 cells per mL is a good predictor for more high ICCCs at subsequent herd tests. This effect was significantly altered in our trial by treatment with penethamate hydriodide at or near the first or second herd test. Whilst in general treatment of high ICCC cows during lactation is considered to be unrewarding, this pilot study suggests that treatment of cows and heifers appropriately selected on the basis of a previous history of low ICCCs can lead to sustained reductions in cell counts. These results support the case for further study into this area.     

Haptoglobin and serum amyloid A in milk from dairy cows with chronic sub-clinical mastitis

New tools are needed to detect chronic sub-clinical mastitis, especially in automatic milking systems. Haptoglobin and serum amyloid A (SAA) are the two most sensitive bovine acute phase proteins, and their concentrations increase in milk from cows with clinical mastitis and in milk from cows with experimentally induced chronic sub-clinical Staphylococcus aureus mastitis. The aim of this study was to further evaluate the potential for haptoglobin and SAA in milk as indicators of chronic sub-clinical mastitis. Quarter milk samples were collected from 41 cows with a mean composite milk somatic cell count (CSCC) above 300,000 cells/mL during at least two months prior to sampling. Quarter milk samples were also taken from eleven cows with a mean CSCC below 80,000 cells/mL during at least two previous months. These samples were analysed for haptoglobin, SAA, adenosine triphosphate (ATP) activity and bacterial growth. The samples were grouped according to their ATP, haptoglobin and SAA status. ATP+ samples had ATP > 2 x 10(-10) mol/mL, Hp+ and SAA+ samples had detectable levels of haptoglobin (> or = 0.3 mg/L) and SAA (> or = 0.9 mg/L), respectively. In udder quarter samples from healthy cows, 42 out of 44 samples belonged to the ATP-Hp-SAA- group. Among cows with chronic sub-clinical mastitis, the ATP+Hp+SAA+ group contained 66 out of 164 samples while 44 samples belonged to the ATP+Hp-SAA- group. Detectable levels of haptoglobin and SAA were found in 92 and 80 samples, respectively. Growth of udder pathogens was detected in 28 samples and Staphylococcus aureus was the most common bacteria. In conclusion, haptoglobin and SAA concentrations below the detection limit were considered as good indicators of healthy udder quarters. A substantial variation in haptoglobin and SAA concentrations in milk was observed in udder quarters with chronic sub-clinical mastitis.